Literature DB >> 19142640

Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases.

Yoko Aoki1, Masahiro Iwamoto, Yasuyuki Kamata, Takao Nagashima, Taku Yoshio, Hitoaki Okazaki, Seiji Minota.   

Abstract

The objective of this study is to investigate the clinical markers of life-threatening Pneumocystis pneumonia (PCP) in patients with collagen vascular diseases (CVD). The patients who contracted Pneumocystis jeroveccii were retrospectively selected from our medical charts and conditions related to the patients' death were reviewed. The findings indicated that lower levels of serum albumin and cholinesterase, increased alveolar-arterial oxygen gradient, intratracheal intubation, and necessity to treat in the intensive care unit were significantly related to deaths associated with PCP in CVD. A special attention should be paid to decreased serum albumin and cholinesterase as ominous predictors in PCP occurred in patients with CVD.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19142640     DOI： 10.1007/s00296-009-0857-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  12 in total

1.  Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.

Authors:  A H Limper; K P Offord; T F Smith; W J Martin
Journal:  Am Rev Respir Dis       Date:  1989-11

2.  Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.

Authors:  M M Ward; F Donald
Journal:  Arthritis Rheum       Date:  1999-04

3.  Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases.

Authors:  Takeo Sato; Shigeko Inokuma; Reika Maezawa; Hisanori Nakayama; Ken Hamasaki; Yusuke Miwa; Yuko Okazaki; Masahiro Yamashita; Yoshiaki Tanaka; Hajime Kono
Journal:  Mod Rheumatol       Date:  2005       Impact factor: 3.023

4.  Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.

Authors:  B Godeau; V Coutant-Perronne; D Le Thi Huong; L Guillevin; G Magadur; M De Bandt; S Dellion; J Rossert; G Rostoker; J C Piette
Journal:  J Rheumatol       Date:  1994-02       Impact factor: 4.666

5.  Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease.

Authors:  Noriko Iikuni; Mariko Kitahama; Shuji Ohta; Hiroshi Okamoto; Naoyuki Kamatani; Makoto Nishinarita
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

6.  Risk factors for hospital-acquired bacteremia.

Authors:  Takuhiro Yoshida; Kenji Tsushima; Ayako Tsuchiya; Noriko Nishikawa; Kumiko Shirahata; Kazuma Kaneko; Ken-Ichi Ito; Hirotaka Kawakami; Shin-Ichi Nakagawa; Toshiro Suzuki; Keishi Kubo; Shu-Ichi Ikeda
Journal:  Intern Med       Date:  2005-11       Impact factor: 1.271

7.  Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy.

Authors:  A Iwama; M Yoshida; A Miwa; T Obayashi; S Sakamoto; Y Miura
Journal:  Eur J Haematol       Date:  1993-09       Impact factor: 2.997

8.  Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases.

Authors:  S M Arend; F P Kroon; J W van't Wout
Journal:  Arch Intern Med       Date:  1995 Dec 11-25

9.  Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases.

Authors:  K Saito; S Nakayamada; K Nakano; M Tokunaga; S Tsujimura; K Nakatsuka; T Adachi; Y Tanaka
Journal:  Rheumatology (Oxford)       Date:  2004-02-03       Impact factor: 7.580

10.  Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients.

Authors:  S Ewig; T Bauer; C Schneider; A Pickenhain; L Pizzulli; U Loos; B Lüderitz
Journal:  Eur Respir J       Date:  1995-09       Impact factor: 16.671
View more
  7 in total

1.  A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.

Authors:  Makoto Kosaka; Atsuhito Ushiki; Yuichi Ikuyama; Kazuya Hirai; Akemi Matsuo; Tsutomu Hachiya; Masayuki Hanaoka
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

2.  Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.

Authors:  Yongfeng Zhang; Yi Zheng
Journal:  Rheumatol Int       Date:  2014-06-20       Impact factor: 2.631

3.  Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes.

Authors:  Yasufumi Matsumura; Yuichiro Shindo; Yoshitsugu Iinuma; Masaki Yamamoto; Michinori Shirano; Aki Matsushima; Miki Nagao; Yutaka Ito; Shunji Takakura; Yoshinori Hasegawa; Satoshi Ichiyama
Journal:  BMC Infect Dis       Date:  2011-03-25       Impact factor: 3.090

4.  Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death.

Authors:  Minjiang Chen; Xinlun Tian; Fang Qin; Jiong Zhou; Jinjing Liu; Mengzhao Wang; Kai-Feng Xu
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

5.  Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients.

Authors:  Lijun Xu; Biao Zhu; Ying Huang; Zongxing Yang; Jia Sun; Yan Xu; Jinlei Zheng; Sabine Kinloch; Michael T Yin; Honglei Weng; Nanping Wu
Journal:  Mediators Inflamm       Date:  2018-03-15       Impact factor: 4.711

6.  A Systematic Review and Meta-Analysis of the Data Behind Current Recommendations for Corticosteroids in Non-HIV-Related PCP: Knowing When You Are on Shaky Foundations.

Authors:  Patil Injean; Samantha J Eells; Hoover Wu; Imani McElroy; Aric L Gregson; James A McKinnell
Journal:  Transplant Direct       Date:  2017-02-15

7.  Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia.

Authors:  Shohei Hamada; Hidenori Ichiyasu; Megumi Inaba; Hiroshi Takahashi; Tomoki Sadamatsu; Kimitaka Akaike; Aiko Masunaga; Yasumasa Tashiro; Naomi Hirata; Takeshi Yoshinaga; Takuro Sakagami
Journal:  ERJ Open Res       Date:  2020-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.